Glenmede Trust’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Glenmede Trust’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-215	Closed	-$8K	–	2056
2020 Q3	$8K	Hold	215	–	–	﹤0.01%	1966
2020 Q2	$8K	Hold	215	–	–	﹤0.01%	1959
2020 Q1	$9K	Hold	215	–	–	﹤0.01%	2478
2019 Q4	$9K	Sell	215 -100	-32%	-$3.71K	﹤0.01%	2478
2019 Q3	$9	Hold	315	–	–	﹤0.01%	2404
2019 Q2	$10	Buy	315 +100	+47%	+$3.45K	﹤0.01%	2377
2019 Q1	$7	Hold	215	–	–	﹤0.01%	2505
2018 Q4	$6	Buy	+215	New	+$7.13K	﹤0.01%	2488
2018 Q2	–	Sell	-215	Closed	-$7K	–	2262
2018 Q1	$7K	Hold	215	–	–	﹤0.01%	2317
2017 Q4	$7K	Hold	215	–	–	﹤0.01%	2317
2017 Q3	$6K	Hold	215	–	–	﹤0.01%	2318
2017 Q2	$5K	Hold	215	–	–	﹤0.01%	2294
2017 Q1	$5K	Hold	215	–	–	﹤0.01%	2294
2016 Q4	$4K	Hold	215	–	–	﹤0.01%	2271
2016 Q3	$5K	Hold	215	–	–	﹤0.01%	2276
2016 Q2	$4K	Hold	215	–	–	﹤0.01%	2287
2016 Q1	$4K	Hold	215	–	–	﹤0.01%	2279
2015 Q4	$6K	Hold	215	–	–	﹤0.01%	2218
2015 Q3	$5K	Hold	215	–	–	﹤0.01%	2307
2015 Q2	$7K	Buy	+215	New	+$7.02K	﹤0.01%	2172

Other funds holding SBIO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Glenmede Trust's SBIO Position: Q4 2020 in Review

Glenmede Trust sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2020, closing a stake of 215 shares — an estimated $8K sold.

Glenmede Trust first reported a position in SBIO in Q2 2015 and held it in 20 quarters. The position peaked at $9K in Q1 2020. 67 funds tracked by Wall St. Rank hold SBIO as of Q4 2020.

Glenmede Trust reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 215 ALPS Medical Breakthroughs ETF shares in Q4 2020, an estimated $8K.
Glenmede Trust first reported a position in ALPS Medical Breakthroughs ETF in Q2 2015 and held it in 20 quarters.
Glenmede Trust's ALPS Medical Breakthroughs ETF position peaked at $9K in Q1 2020.
67 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.